ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

XRAY DENTSPLY SIRONA Inc

30.01
-0.68 (-2.22%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
DENTSPLY SIRONA Inc NASDAQ:XRAY NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.68 -2.22% 30.01 29.51 30.62 30.39 29.94 30.095 2,331,882 01:00:00

Current Report Filing (8-k)

14/12/2017 10:06pm

Edgar (US Regulatory)




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934


December 14, 2017 (December 12, 2017)
Date of Report (Date of earliest event reported)

0-16211
(Commission File Number)

DENTSPLY SIRONA Inc.
(Exact name of registrant as specified in its charter)

 
 
 
 
 
Delaware
 
39-1434669
(State of Incorporation)
 
(IRS Employer Identification No.)
 
 
 
 
 
 
 
 
 
 
221 West Philadelphia Street,
 
 
 
York, Pennsylvania
 
17401-2991
(Address of principal executive offices)
 
 (Zip Code)
 
 
 
 
 
Registrant's telephone number, including area code:
(717) 845-7511
 

    
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))










Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

Effective December 12, 2017, DENTSPLY SIRONA Inc. (the “Company”) appointed Nicholas W. Alexos, Executive Vice President and Chief Financial Officer, as principal accounting officer for purposes of the Company’s filings with the Securities and Exchange Commission in addition to his current role. Mr. Alexos, age 54, will oversee the Company’s accounting matters.

Since November 10, 2017, Mr. Alexos has served as the Executive Vice President and Chief Financial Officer of the Company. Prior to assuming the role of Executive Vice President and Chief Financial Officer for the Company, from January 1993 to October 2017, Mr. Alexos served as Managing Director of Madison Dearborn Partners LLC, a Chicago-based private equity firm which he co-founded, where he was responsible for investment activities in healthcare and general management of the firm. Mr. Alexos is a certified public accountant and he received his B.B.A. from Loyola University and an M.B.A. from The University of Chicago Booth School of Business.

Mr. Alexos has no family relationships with any director, executive officer, or person nominated or chosen by the Company to become an officer of the Company. Mr. Alexos is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.






SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



DENTSPLY SIRONA Inc.

By:      /s/ Keith J. Ebling     
Keith J. Ebling,
Executive Vice President, Secretary and
General Counsel
            


Date: December 14, 2017



1 Year DENTSPLY SIRONA Chart

1 Year DENTSPLY SIRONA Chart

1 Month DENTSPLY SIRONA Chart

1 Month DENTSPLY SIRONA Chart

Your Recent History

Delayed Upgrade Clock